Publications by authors named "Aissatou Bintou Khairy Thilor Ndiaye"
Objective: To determine how neonatal growth velocity affects the association between birth weight and neurodevelopmental outcomes in infants born preterm.
Study Design: This study is a secondary analysis of the Maternal Omega-3 Supplementation to Reduce Bronchopulmonary Dysplasia in Very Preterm Infants (MOBYDIck) randomized multicenter trial conducted in breastfed infants born at <29 weeks of gestation, whose mothers were supplemented with docosahexaenoic acid or placebo during the neonatal period. Neurodevelopmental outcomes were assessed at 18-22 months of corrected age using the Bayley-III cognitive and language composite scores.
Article Synopsis
- The study aimed to investigate if maternal high-dose DHA supplementation improved neurodevelopment in very preterm neonates at 18 to 22 months corrected age.
- A randomized, double-blind, placebo-controlled trial was conducted with lactating mothers of preterm neonates, comparing outcomes for children whose mothers took DHA-rich algae oil and those on a placebo.
- Results showed no overall improvement in cognitive, language, or motor scores between the two groups, but a notable benefit in language scores for neonates born before 27 weeks’ gestation who received DHA.
Introduction: The aim of the study was to determine the effect of a maternal docosahexaenoic acid (DHA) supplementation during lactation, compared with a placebo, on the neonatal growth profile of breastfed very preterm infants.
Methods: Preterm infants' growth profile, growth velocity from birth to 36 weeks' postmenstrual age (PMA), and growth at 36 weeks' PMA were pre-specified secondary outcomes of a randomized placebo-controlled trial conducted in 16 Canadian neonatal intensive care units (2015-2018). Lactating mothers who delivered before 29 weeks' gestation were given 1.